Podcast Episode
Sequencing agents in HER2 mutant lung cancer
About this episode
How I think agents should be sequenced in HER2 mutant lung cancer.
Case report on zongertinib upregulating HER2 receptors: https://pmc.ncbi.nlm.nih.gov/articles/PMC12964209/